Assembly Biosciences Inc
NASDAQ:ASMB

Watchlist Manager
Assembly Biosciences Inc Logo
Assembly Biosciences Inc
NASDAQ:ASMB
Watchlist
Price: 35.26 USD 9% Market Closed
Market Cap: 557.8m USD

Intrinsic Value

The intrinsic value of one ASMB stock under the Base Case scenario is 22.03 USD. Compared to the current market price of 35.26 USD, Assembly Biosciences Inc is Overvalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ASMB Intrinsic Value
22.03 USD
Overvaluation 38%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Assembly Biosciences Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about ASMB?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ASMB valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Assembly Biosciences Inc.

Explain Valuation
Compare ASMB to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ASMB?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Assembly Biosciences Inc

Current Assets 236.8m
Cash & Short-Term Investments 232.6m
Receivables 912k
Other Current Assets 3.3m
Non-Current Assets 3.2m
PP&E 2.9m
Other Non-Current Assets 312k
Current Liabilities 53.4m
Accounts Payable 1.7m
Accrued Liabilities 9.3m
Other Current Liabilities 42.4m
Non-Current Liabilities 3.9m
Other Non-Current Liabilities 3.9m
Efficiency

Free Cash Flow Analysis
Assembly Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Assembly Biosciences Inc

Revenue
37.2m USD
Operating Expenses
-80.6m USD
Operating Income
-43.4m USD
Other Expenses
4.9m USD
Net Income
-38.5m USD
Fundamental Scores

ASMB Profitability Score
Profitability Due Diligence

Assembly Biosciences Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Low 3Y Average Gross Margin
Low Gross Margin
Negative 3Y Average Net Margin
17/100
Profitability
Score

Assembly Biosciences Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

ASMB Solvency Score
Solvency Due Diligence

Assembly Biosciences Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Assembly Biosciences Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ASMB Price Targets Summary
Assembly Biosciences Inc

Wall Street analysts forecast ASMB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASMB is 39.02 USD with a low forecast of 29.29 USD and a high forecast of 52.5 USD.

Lowest
Price Target
29.29 USD
17% Downside
Average
Price Target
39.02 USD
11% Upside
Highest
Price Target
52.5 USD
49% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Assembly Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ASMB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ASMB Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ASMB stock?

The intrinsic value of one ASMB stock under the Base Case scenario is 22.03 USD.

Is ASMB stock undervalued or overvalued?

Compared to the current market price of 35.26 USD, Assembly Biosciences Inc is Overvalued by 38%.

Back to Top